QUMAS today announced that Retroscreen Virology has selected the QUMAS Quality Management Solution to manage all of its regulatory and quality content and processes, including SOPs, CAPAs, and Audits.
Retroscreen Virology, a UK based virology healthcare company specializing in anti-viral research and the conduct of human viral challenge studies, will be deploying the QUMAS Quality Management Solution to over 70% of its employees across the company.
The industry leading Quality Management Solution from QUMAS provides Retroscreen Virology with a closed-loop compliance and quality management solution that delivers comprehensive capabilities around document management (SOPs, methods, procedures, etc.) and meets all of their needs for quality process management (CAPAs, Audits, etc.), presenting these through a unified user interface, with consolidated reporting and dashboarding, all driving regulatory compliance and ultimately delivering better business performance.
“We have been experiencing strong growth over the last two years and realized that we need to quickly move to an automated solution to manage our quality documents and processes,” stated Sarah Howard, Director of Regulatory and Quality Governance at Retroscreen Virology. “Key factors in selecting QUMAS were that their platform can scale as our company grows, and comes pre-configured and pre-tested enabling us to rapidly roll out the solution to all of our employees. Additionally, the QUMAS services team has an excellent track record in the industry.”
“We are excited to have Retroscreen Virology come on board as another contract research organization customer in the United Kingdom,” said Kevin O’Leary, CEO for QUMAS. “We are looking forward to working closely with the Retroscreen Virology on the corporate wide implementation of our compliance solution.”
About Retroscreen Virology
Retroscreen is a virology healthcare business that provides clinical services, focused on the Viral Challenge Model (“VCM”), and pre-clinical analytical services, primarily to global pharmaceutical companies and biotechnology organisations. Retroscreen has grown and developed the VCM for evidencing the efficacy of antiviral and viral therapeutics in flu, cold and RSV viruses.
Retroscreen is focused on revenue growth, building capacity and pioneering a new way to conduct clinical trials in the development of drugs against virus, with the goal of dominating its space and pushing the bounds of scientific knowledge and understanding in virology.
For more information visit www.retroscreen.com.
QUMAS is the leader in Enterprise Compliance Solutions with more than 250 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Gold Microsoft Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, Documentum, Oracle or SQL. For more information, visit www.qumas.com.